Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹1,000

Baroda BNP Paribas Health & Wellness IDCW Reinvest Direct Plan

NAV
₹9.6404
-1.00%
(8 Jan)
AUM
587 Cr
TER
0.43%
Risk
Very High Risk
Insights
Total Expense Ratio (TER) is in the bottom 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+14.6%
+5.2%
+5.2%
+5.2%
NA
3Y
+31.0%
+31.2%
+31.2%
+31.2%
NA
5Y
+28.6%
+22.4%
+22.4%
+22.4%
NA
ALL
+16.8%
+17.7%
+17.7%
+17.7%
-3.6%
VOL
20.1%
17.8%
17.8%
17.8%
9.4%
TER
0.9%
0.5%
0.5%
0.5%
0.4%
AUM
₹1,445 Cr
₹8,304 Cr
₹8,304 Cr
₹8,304 Cr
₹587 Cr
INFO
0.83
0.99
0.99
0.99
-0.38
See fund holdings as of 30th Nov
Top holdings
Sun Pharmaceuticals Industries Ltd
9.0%
Mankind Pharma Ltd
7.0%
Cipla Ltd
6.5%
Max Healthcare Institute Ltd Ordinary Shares
6.3%
Apollo Hospitals Enterprise Ltd
6.0%
Aster DM Healthcare Ltd Ordinary Shares
4.9%
Abbott India Ltd
4.8%
Divi's Laboratories Ltd
4.2%
Torrent Pharmaceuticals Ltd
4.0%
AstraZeneca Pharma India Ltd
3.8%
Top industry exposure
Healthcare
93.8%
Financial Services
2.9%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹1,000
Additional lumpsum
₹1,000
Portfolio turnover
24%
Lock-in period
-
Exit load
• 1% for redemption within 365 days
Fund objective
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.
Fund manager(s)
Sanjay Chawla

FAQs